Evidence map›Paper›PMID 31602011›Full record

Observational studyScientific reports2019

Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study.

Takahisa Hiramitsu, Toshihide Tomosugi, Manabu Okada, Kenta Futamura, Makoto Tsujita, Norihiko Goto, Shunji Narumi, Yoshihiko Watarai, Yoshihiro Tominaga, Toshihiro Ichimori

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Cautious clinical interpretation of preoperative Tc-Surgery in practice and science · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Semiquantitative assessment ofFrontiers in endocrinology · 2022
    Article
  16. Surgical Management of Secondary Hyperparathyroidism.Kidney international reports · 2021
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Takahisa HiramitsuNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan. thira@nagoya2.jrc.or.jp.
Toshihide TomosugiNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Manabu OkadaNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Kenta FutamuraNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Makoto TsujitaNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Norihiko GotoNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Shunji NarumiNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Yoshihiko WataraiNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Yoshihiro TominagaNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Toshihiro IchimoriNagoya Daini Red Cross Hospital, Department of Transplant and Endocrine Surgery, 466-8650, 2-9 Myoken-cho, Showa-ku, Nagoya, Aichi, Japan.
Japanese Red Cross Nagoya Daini Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complete parathyroidectomy (PTx) is essential during total PTx for secondary hyperparathyroidism (SHPT) to prevent recurrent and persistent hyperparathyroidism. Pre-operative imaging evaluations, including computed tomography (CT), ultrasonography (US), and Tc-99m sestamibi (MIBI) scans, are commonly performed. Between June 2009 and January 2016, 291 patients underwent PTx for SHPT after pre-operative evaluations involving CT, US, and MIBI scans, and the diagnostic accuracies of these imaging modalities for identifying the parathyroid glands were evaluated in 177 patients whose intact parathyroid hormone (PTH) levels were <9 pg/mL after the initial PTx. Additional PTx procedures were performed on 7 of 114 patients whose intact PTH levels were >9 ng/mL after PTx, and the diagnostic validities of the imaging modalities for the remnant parathyroid glands were evaluated. A combination of CT, US, and MIBI scans achieved the highest diagnostic accuracy (75%) for locating bilateral upper and lower parathyroid glands before initial PTx. The accuracies of CT, US, and MIBI scans with respect to locating remnant parathyroid glands before additional PTx were 100%, 28.6%, and 100%, respectively. A combination of CT, US, and MIBI scans is useful for initial PTx for SHPT, and CT and MIBI scans are useful imaging modalities for additional PTx procedures.

Indexed as

ParathyroidectomyAdultAgedFemaleHumansHyperparathyroidism, SecondaryKidney Failure, ChronicMaleMiddle AgedMultimodal ImagingParathyroid GlandsParathyroid HormonePreoperative CareRadionuclide ImagingRadiopharmaceuticalsRetrospective StudiesParathyroid HormoneRadiopharmaceuticalsTechnetium Tc 99m Sestamibi

Identifiers

PMID31602011
PMCPMC6787184
OpenAlexW2980051005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.